Thanks.
Looking at the Indonesian market, we see an opportunity for all canola products, seed, oil and meal. With respect to the list of non-tariff barriers, I think we often think of a non-tariff barrier as an issue or barrier that we're currently facing that is preventing current access. However, a non-tariff barrier could also be something that is impacting our decision to sell into a market. From a canola perspective, we often need approvals of biotech varieties in markets before we will consider them. If we're using a crop protection product, we also need to have a maximum residue limit in place. There are also some barriers that need to be resolved before we can even consider selling into a market. There are two sides to the non-tariff barrier conversation or perspective.
As Dave said, as far as Indonesia goes, we are very much looking for clear, prescriptive rules on how agriculture biotechnology will be managed and how missing and misaligned approvals of crop protection products will be considered, to ensure that we have a pathway and an environment in place, before we sell into that market, that allow our exports to pivot easily between the two without having to go through all the regulatory approvals before they can access them.